A Phase II, Double-Blind, Placebo-Controlled, Trial Of NS2359 For The Treatment of Cocaine Dependence

Trial Profile

A Phase II, Double-Blind, Placebo-Controlled, Trial Of NS2359 For The Treatment of Cocaine Dependence

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs NS 2359 (Primary)
  • Indications Cocaine abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2016 Status changed from not yet recruiting to recruiting.
    • 16 Dec 2015 According to Saniona's media release, in June, Saniona has granted rights to Treatment Research Center (TRC), to perform this trial.
    • 16 Dec 2015 According to Saniona's media release, company is planning to initiate this trial during the first of 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top